Literature DB >> 32258018

Regression of Periocular Basal Cell Carcinoma: A Report of Four Cases with Clinicopathologic Correlation.

Martina C Herwig-Carl1, Karin U Loeffler1.   

Abstract

OBJECTIVES: To describe the spectrum of clinical and histopathological features of a case series of basal cell carcinoma (BCC) with spontaneous regression and to discuss this phenomenon.
METHOD: Four cases of BCC with complete/substantial regression were retrospectively identified. Patients' records were analyzed for demographic data, clinical appearance, and the postoperative course. Formalin-fixed, paraffin-embedded specimens were routinely processed and stained with hematoxylin and eosin and periodic acid Schiff.
RESULTS: Complete (n = 1) or partial (n = 3) regression of BCC was observed in 4 patients. Two lesions at the medial canthus were histologically diagnosed as nodular BCC with significant regression. One lesion at the lower eyelid exhibited a complete regression which did not require surgical intervention. The other lesion at the lower eyelid presenting with ulceration and madarosis was excised. Scar tissue without evidence for a neoplasm was present histologically. Subsequently, the patient developed a recurrence with a histologically proven micronodular BCC.
CONCLUSIONS: BCC can show spontaneous substantial or complete regression. Histological tumor absence in lesions which are clinically suspicious for a neoplasm can be a hint for a regressive BCC. Recurrences may develop from remaining tumor islands warranting periodical clinical visits in cases of clinically as well as histologically suspected regressive BCC.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Basal cell carcinoma; Histology; T lymphocytes; Tumor regression

Year:  2019        PMID: 32258018      PMCID: PMC7109437          DOI: 10.1159/000501370

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  38 in total

1.  In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma.

Authors:  Vincenzo De Giorgi; Camilla Salvini; Alessandra Chiarugi; Milena Paglierani; Vincenza Maio; Paola Nicoletti; Marco Santucci; Paolo Carli; Daniela Massi
Journal:  Int J Dermatol       Date:  2009-03       Impact factor: 2.736

2.  Basal cell carcinoma: analysis of regression after incomplete excision.

Authors:  V Zemelman; P Silva; I Sazunic
Journal:  Clin Exp Dermatol       Date:  2009-08-17       Impact factor: 3.470

3.  'The nodule that disappeared' spontaneous regression of an eyelid noduloulcerative lesion mimicking the features of a basal cell carcinoma.

Authors:  Tafadzwa Young-Zvandasara; Magdalena Popiela; Garry Shuttleworth
Journal:  BMJ Case Rep       Date:  2015-01-29

4.  Statin use and risk of skin cancer.

Authors:  Brian M Lin; Wen-Qing Li; Eunyoung Cho; Gary C Curhan; Abrar A Qureshi
Journal:  J Am Acad Dermatol       Date:  2017-12-05       Impact factor: 11.527

5.  Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide.

Authors:  S A Buechner; M Wernli; T Harr; S Hahn; P Itin; P Erb
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

6.  Cytokine profiles in spontaneously regressing basal cell carcinomas.

Authors:  D A Wong; G A Bishop; M A Lowes; B Cooke; R S Barnetson; G M Halliday
Journal:  Br J Dermatol       Date:  2000-07       Impact factor: 9.302

7.  Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas.

Authors:  Elena Garcia-Martin; Miriam Idoipe; Laura Maria Gil; Victoria Pueyo; Jorge Alfaro; Luis E Pablo; Maria Luisa Zubiri; Javier Fernandez
Journal:  J Ocul Pharmacol Ther       Date:  2010-08       Impact factor: 2.671

8.  Episodic progression and regression of basal cell carcinomas.

Authors:  C Franchimont; G E Pierard; D Van Cauwenberge; M Damseaux; C H Lapiere
Journal:  Br J Dermatol       Date:  1982-03       Impact factor: 9.302

9.  Immunosuppressive Environment in Basal Cell Carcinoma: The Role of Regulatory T Cells.

Authors:  Silje H Omland; Patricia S Nielsen; Lise M R Gjerdrum; Robert Gniadecki
Journal:  Acta Derm Venereol       Date:  2016-11-02       Impact factor: 4.437

10.  Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells.

Authors:  G M Halliday; A Patel; M J Hunt; F J Tefany; R S Barnetson
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.